Fennell D - Search Results

1

KDM6B histone demethylase is an epigenetic regulator of estrogen receptor β expression in human pleural mesothelioma.

Manente AG, Pinton G, Zonca S, Tavian D, Habib T, Jithesh PV, Fennell D, Nilsson S, Moro L. Manente AG, et al. Among authors: fennell d. Epigenomics. 2016 Sep;8(9):1227-38. doi: 10.2217/epi-2016-0025. Epub 2016 Aug 16. Epigenomics. 2016. PMID: 27529370 Free article.

2

Estrogen receptor-beta affects the prognosis of human malignant mesothelioma.

Pinton G, Brunelli E, Murer B, Puntoni R, Puntoni M, Fennell DA, Gaudino G, Mutti L, Moro L. Pinton G, et al. Cancer Res. 2009 Jun 1;69(11):4598-604. doi: 10.1158/0008-5472.CAN-08-4523. Cancer Res. 2009. PMID: 19487281

3

Gene expression meta-analysis identifies VDAC1 as a predictor of poor outcome in early stage non-small cell lung cancer.

Grills C, Jithesh PV, Blayney J, Zhang SD, Fennell DA. Grills C, et al. PLoS One. 2011 Jan 31;6(1):e14635. doi: 10.1371/journal.pone.0014635. PLoS One. 2011. PMID: 21297950 Free PMC article.

4

Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo.

Manente AG, Valenti D, Pinton G, Jithesh PV, Daga A, Rossi L, Gray SG, O'Byrne KJ, Fennell DA, Vacca RA, Nilsson S, Mutti L, Moro L. Manente AG, et al. Among authors: fennell da. Oncogenesis. 2013 Sep 23;2(9):e72. doi: 10.1038/oncsis.2013.32. Oncogenesis. 2013. PMID: 24061575 Free PMC article.

5

SIRT1 at the crossroads of AKT1 and ERβ in malignant pleural mesothelioma cells.

Pinton G, Zonca S, Manente AG, Cavaletto M, Borroni E, Daga A, Jithesh PV, Fennell D, Nilsson S, Moro L. Pinton G, et al. Among authors: fennell d. Oncotarget. 2016 Mar 22;7(12):14366-79. doi: 10.18632/oncotarget.7321. Oncotarget. 2016. PMID: 26885609 Free PMC article.

6

Analysis of Gene Expression in 3D Spheroids Highlights a Survival Role for ASS1 in Mesothelioma.

Barbone D, Van Dam L, Follo C, Jithesh PV, Zhang SD, Richards WG, Bueno R, Fennell DA, Broaddus VC. Barbone D, et al. Among authors: fennell da. PLoS One. 2016 Mar 16;11(3):e0150044. doi: 10.1371/journal.pone.0150044. eCollection 2016. PLoS One. 2016. PMID: 26982031 Free PMC article.

7

CDKN2A Determines Mesothelioma Cell Fate to EZH2 Inhibition.

Pinton G, Wang Z, Balzano C, Missaglia S, Tavian D, Boldorini R, Fennell DA, Griffin M, Moro L. Pinton G, et al. Among authors: fennell da. Front Oncol. 2021 Jul 1;11:678447. doi: 10.3389/fonc.2021.678447. eCollection 2021. Front Oncol. 2021. PMID: 34277422 Free PMC article.

8

How does the timing of chemotherapy affect outcome following radical surgery for malignant pleural mesothelioma?

Sharkey AJ, O'Byrne KJ, Nakas A, Tenconi S, Fennell DA, Waller DA. Sharkey AJ, et al. Lung Cancer. 2016 Oct;100:5-13. doi: 10.1016/j.lungcan.2016.07.023. Epub 2016 Jul 22. Lung Cancer. 2016. PMID: 27597274

9

Targeting the tumour vasculature in mesothelioma.

Fennell DA. Fennell DA. Lancet Oncol. 2018 Jun;19(6):723-724. doi: 10.1016/S1470-2045(18)30248-1. Epub 2018 May 9. Lancet Oncol. 2018. PMID: 29753701 No abstract available.

10

Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma.

Creaney J, Patch AM, Addala V, Sneddon SA, Nones K, Dick IM, Lee YCG, Newell F, Rouse EJ, Naeini MM, Kondrashova O, Lakis V, Nakas A, Waller D, Sharkey A, Mukhopadhyay P, Kazakoff SH, Koufariotis LT, Davidson AL, Ramarao-Milne P, Holmes O, Xu Q, Leonard C, Wood S, Grimmond SM, Bueno R, Fennell DA, Pearson JV, Robinson BW, Waddell N. Creaney J, et al. Among authors: fennell da. Genome Med. 2022 May 30;14(1):58. doi: 10.1186/s13073-022-01060-8. Genome Med. 2022. PMID: 35637530 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

301 results

Search Page